{"id":"W2967398918","doi":"10.1016/s1470-2045(19)30407-3","title":"Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis","year":2019,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":365,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Cancer Institute; Bristol-Myers Squibb; Ono Pharmaceutical; European Society for Medical Oncology; Cancer Research Society; American Association for Cancer Research","keywords":"Nivolumab; Medicine; Docetaxel; Lung cancer; Internal medicine; Oncology; Clinical trial; Survival analysis; Cancer; Progressive disease; Chemotherapy; Immunotherapy","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005157535,0.002136721,0.006025526,0.001620958,0.0003209836,0.001808459,0.001270487,0.001489179,0.001708967],"category_scores_gemma":[0.00508872,0.001066874,0.02551352,0.001954605,0.0003789555,0.001385301,0.001316797,0.001543291,0.0003768342],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00115344,"about_ca_system_score_gemma":0.000798647,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007430982,"about_ca_topic_score_gemma":0.01448563,"domain_scores_codex":[0.9959566,0.001635604,0.0005028402,0.001162867,0.0003530558,0.0003890284],"domain_scores_gemma":[0.9976397,0.0009409439,0.0006132604,0.0003525204,0.0002958965,0.0001577418],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.09401312,0.000159461,0.186668,0.004875177,0.6811141,0.0002792383,0.00009390851,0.004516753,0.001851146,0.0001560592,0.002769675,0.0235034],"study_design_scores_gemma":[0.009521678,0.004877861,0.3944926,0.0006006867,0.5796785,0.0003817773,0.0002347144,0.004608321,0.0006537928,0.0005601639,0.004225041,0.0001648271],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.842942,0.139849,0.003329445,0.0004359311,0.0009528509,0.0002078056,0.009822551,0.0001672184,0.002293296],"genre_scores_gemma":[0.9829947,0.008695923,0.0007431147,0.0004633594,0.0004183522,0.0001550502,0.005398121,0.00005762657,0.001073757],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007430982,"threshold_uncertainty_score":0.02727598,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01116992741928595,"score_gpt":0.26970985525713,"score_spread":0.258539927837844,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}